A genetics diagnostics company
offering genetics testing to
a global clinical community


Blueprint Genetics provides comprehensive genetics testing for all medical specialties. Blueprints innovative technologies in human rare diseases enable improved tests with higher quality, lower cost and faster lead time. We offer full transparency to our technology, quality and performance, and analytic validations of our technologies.

Our expert team of geneticists and clinicians together with our AI powered CLINT technology provide top quality clinical interpretation and reports, changing the standards of molecular diagnostics. We are accredited by ISO 15189 and CAP (#9257331), and certified by CLIA (#99D2092375).

Inventure joined Blueprint Genetics in 2014.


Interested in attending webinars from the world of #genetics? Access our webinar archive. Our no-cost webinars cover a wide range of topics from understanding VUSs to getting the most from #WholeExomeSequencing. Watch the recordings at your convenience:

What makes the difference in #genetictesting? @SamuMyllykangas mentions two things that are enabled by having a strong focus in quality: 1) Resolving genetic variations in difficult-to-sequence regions and 2) detecting small deletions and duplications. #BlueprintAcademy

Aspects of quality in #genetictesting: scientific justification for clinical utility, and communicating the possible limitations of the test. Important to also add deep intronic non-coding variants to the gene design, @SamuMyllykangas lists in #BlueprintAcademy webinar.